PRESS RELEASE published on 03/07/2025 at 07:30, 10 months 22 days ago Inside Information / Other news releases Sensorion completes patient enrollment in NOTOXIS Phase 2a Clinical Trial of SENS-401 for Cisplatin-Induced Ototoxicity prevention, targeting a significant unmet medical need Clinical Trial Sensorion SENS-401 NOTOXIS Cisplatin-Induced Ototoxicity
BRIEF published on 02/21/2025 at 07:35, 11 months 8 days ago Sensorion's SENS-501 Clinical Trial Progresses with Positive DMC Recommendation Gene Therapy Clinical Trial Sensorion Hearing Loss SENS-501
PRESS RELEASE published on 02/21/2025 at 07:30, 11 months 8 days ago Inside Information / Other news releases Sensorion receives positive recommendation from Data Monitoring Committee for Audiogene Phase 1/2 clinical trial of SENS-501 gene therapy program to treat congenital deafness linked to OTOF gene mutations Gene Therapy Sensorion Audiogene Deafness Data Monitoring Committee
BRIEF published on 02/20/2025 at 07:35, 11 months 9 days ago Sensorion to Participate in March Investor Conferences Biotechnology Investor Conferences Sensorion Hearing Loss Therapies March 2025
PRESS RELEASE published on 02/20/2025 at 07:30, 11 months 9 days ago Inside Information / Other news releases Sensorion announces participation in investor conferences in March. CEO and CFO will attend Cowen and Leerink events to present company updates and meet investors Biotechnology CFO Investor Conferences CEO Sensorion
BRIEF published on 02/18/2025 at 07:35, 11 months 11 days ago Sensorion announces its participation in congresses in March 2025 Biotechnology Sensorion Hearing Therapies Medical Innovations Congress 2025
PRESS RELEASE published on 02/18/2025 at 07:30, 11 months 11 days ago Inside Information / Other news releases Sensorion announces participation in upcoming congresses in March to present on innovative biologics and manufacturing challenges for hearing loss disorders Sensorion Hearing Loss Biologics Congresses Manufacturing Challenges
BRIEF published on 02/12/2025 at 11:35, 11 months 16 days ago Sensorion to Participate in ARO 48th Annual Midwinter Meeting Sensorion Hearing Loss ARO Meeting GJB2-GT Therapy Biotech Conference
PRESS RELEASE published on 02/12/2025 at 11:30, 11 months 16 days ago Inside Information / Other news releases Sensorion announces participation in ARO 48th Annual Midwinter Meeting with focus on gene therapy for deafness. Details of presentations by Sensorion executives included Gene Therapy Sensorion ARO Meeting Deafness Sensorion Executives
BRIEF published on 12/27/2024 at 07:35, 1 year 1 month ago Sensorion Completes Enrollment for Audiogene Phase 1/2 Trial Gene Therapy Sensorion Hearing Loss SENS-501 Audiogene Trial
Published on 01/29/2026 at 03:30, 5 hours 2 minutes ago NuRAN Provides Clarification and Corrections Regarding Restructuring Transaction Disclosure
Published on 01/29/2026 at 02:15, 6 hours 17 minutes ago McEwen Inc. to Acquire Golden Lake Exploration Inc.
Published on 01/29/2026 at 01:50, 6 hours 42 minutes ago Alphinat Announces a Net Profit of $89,282 for Quarter Ended November 30, 2025
Published on 01/29/2026 at 00:00, 8 hours 32 minutes ago Tokenwell Adds Single-Coin Trading Capabilities and Expands Exchange Support
Published on 01/28/2026 at 23:45, 8 hours 47 minutes ago CoTec Holdings Corp. Announces Warrant Exercise by Kings Chapel
Published on 01/29/2026 at 08:20, 12 minutes ago Innovative and Immersive, ISLE 2026 to Define the Future of Display and Integration
Published on 01/29/2026 at 08:05, 27 minutes ago Roma Embassy in The Hague officially established for diplomatic relations
Published on 01/29/2026 at 07:30, 1 hour 2 minutes ago Steyr Motors receives development contract from a leading international defense and technology group based in Singapore
Published on 01/28/2026 at 18:00, 14 hours 32 minutes ago Launch of Skira Education Systems and acquisition of Institut Beau Cèdre
Published on 01/28/2026 at 17:45, 14 hours 47 minutes ago Infotel : Q4 2025 revenue up +3.5%. Acquisition of Sesin, a specialist in EDM. A promising start to 2026
Published on 01/28/2026 at 17:40, 14 hours 52 minutes ago Mersen: Sales of €1.2 billion in 2025, in line with expectations
